Picture of Timken logo

TKR — Timken News Story

0.000.00%
us flag iconLast trade - 00:00
IndustrialsBalancedLarge CapSuper Stock

Timken Co reports results for the quarter ended September 30 - Earnings Summary

Timken Co reports results for the quarter ended September 30 - Earnings Summary
  • Timken Co TKR.N reported quarterly adjusted earnings of $1.65​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $1.37. The mean expectation of twelve analysts for the quarter was for earnings of $1.48 per share. Wall Street expected results to range from $1.41 to $1.54 per share.

  • Revenue rose 4.7% to $1.21 billion from a year ago; analysts expected $1.21 billion.

  • Timken Co's reported EPS for the quarter was $1.34​.

  • The company reported quarterly net income of $93.8 million.

  • Timken Co shares had fallen by 0.9% this quarter and gained 37.5% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had fallen by about 0.9% in the last three months.​

  • In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell." The average consensus recommendation for the industrial machinery & equipment peer group is also "buy"

  • Wall Street's median 12-month price target for Timken Co is $137.50, about 15.9% above its last closing price of $115.66

This summary was machine generated from LSEG data November 4 at 02:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Sep. 30 2026

1.48

1.65

Beat

Jun. 30 2026

1.62

1.83

Beat

Mar. 31 2026

1.49

1.67

Beat

Dec. 31 2025

1.09

1.14

Beat

Recent news on Timken

See all news